of intracellular Ca2+ signals in response to Ca2+ -mobilizing stimuli is a critical event in the control of many cellular processes. Inositol 1,4,5-trisphosphate (IP3) represents a dominant second messenger subserving the release of Ca2+ from intracellular store sites. The protein on the surface of which the IP3 receptor is located comprises an IP3-gated Ca2+ channel, and binding of IP3 to this receptor triggers the release of Ca2+ through this channel. The receptor for IP3 displays a close resemblance to the ryanodine receptor, another intracellular Ca2+ channel, in many molecular and physiological properties. Many lines of evidence strongly suggest the central role that the IP3 receptor plays in the conversion of numerous external stimuli to intracellular Ca2+ signals characterized by complex spatiotemporal patterns such as Ca2+ waves and oscillations. In this review, we shall summarize our current knowledge of the structure and function of the IP3 receptor in order to understand the way how the activity of this important receptor is regulated to accomodate itself to the generation of diverse intracellular Ca2+ signals.
I. Introduction
Intracellular calcium plays a crucial role in the control of many cellular processes as diverse as cell motility, con traction, secretion, cell proliferation, sensory perception and neuronal signaling (1) (2) (3) (4) . Generation of intracellular Ca2+ signals with complex spatiotemporal patterns is dynamically and precisely controlled by both the entry of external Ca2+ and the release of internal Ca2+. In response to many stimuli such as neurotransmitters, hormones and growth factors, phosphatidylinositol 4,5 bisphosphate (PIP2) in the plasma membrane is hydro lyzed by phospholipase C (PLC) to produce inositol 1,4,5-trisphosphate (IP3) and diacylglycerol (DAG). IP3 plays a dominant role as a second messenger molecule for the release of Ca 21 from intracellular stores, while DAG activates protein kinase C (PKC). It binds to an intra cellular receptor (IP3 receptor) located on the surface of intracellular Ca2+ stores. The IP3 receptor is at the same time a release channel for luminal Ca2+ whose molecular and physiological properties closely resemble those of another intracellular, Ca2+-mobilizing channel, i.e., the ryanodine receptor. Ca2+ release occurs upon binding of IP3 to the receptor. Thus, the IP3 receptor plays a central role in conversion of IP3 signals produced by external stimuli to intracellular Ca 21 signals. Many lines of evi dence now indicate that regenerative, intricately regulated Ca2+ release through these intracellular Ca2+ channels is mainly responsible for generation of intracellular Ca2+ signals with complex spatiotemporal patterns such as cal cium waves and oscillations. In this review, we shall sum marize the current understanding of the structure and function of the IP3 receptor to understand the way how the activity of the IP3 receptor is regulated to accommo date itself to generation of diverse intracellular Ca 2+ sig nals. Several reviews (5 10) can be consulted for infor mation not focused on in this article. Trends Journals, Cambridge (1996), which was compiled in association with the IUPHAR.
II. Formation of IP3
Formation of IP3 is prerequisite for both the release of Ca2+ from intracellular stores as well as the entry of ex ternal Ca2+. There are two major pathways for hydrolysis of PIP2 to IP3: one is initiated by G protein-linked recep tors characterized by the presence of seven transmem brane-spanning domains in their molecules and the other by tyrosine kinase-linked receptors characterized by a single transmembrane-spanning domain ( Table 1 ). The G protein-linked receptors stimulate PLC(3 isozymes, while the tyrosine kinase-linked receptors stimulate PLCr iso zymes to convert PIP2 to IP3 and DAG. Both pertussis toxin-sensitive and -insensitive heterotrimeric G proteins link the activation of receptors with the stimulation of PLC (3 (11) . Upon activation, the heterotrimeric G pro teins dissociate into Ga and GP, subunits, both of which stimulate different PLC isozymes (12) . The involvement of pertussis toxin-insensitive Gqa and other members of the family, Ga11, Ga14 and Ga16, in the stimulation of PLC(3 is now well-established. The pertussis toxin-sensi tive G proteins that mediate PLC stimulation are less well-characterized, although the involvement of G.,, and G;a subunits has been suggested (13) . Stimulation of PLC(3 by Gtr subunits is now firmly established (12) . Ga and GP, subunits appear to interact with distinct sites of the PLC~ molecule, implicating independent regulation by both subunits of the heterotrimeric G protein.
Tyrosine kinase receptors such as receptors for platelet-derived growth factor and epidermal growth fac tor (Table 1) generate IP3 by direct stimulation of PLCr. These receptor molecules contain cytoplasmic tyrosine kinase domains. Upon ligand binding, the receptor dimerizes and autophosphorylates each other on specific tyrosine residues that form the docking sites responsible for interaction with the SH2 domains of PLCr. Interac tion of PLCr with the specific phosphotyrosine residues of receptors brings about phosphorylation of the PLCr on at least 3 tyrosine residues and leads to stimulation of the enzyme and production of IP3 and DAG (2) . A similar PLCr stimulation process operates in the activation of IgM receptors in B lymphocytes and the activation of T-cell antigen receptors. These receptors lack tyrosine kinase domains but they recruit cytoplasmic src family tyrosine kinases such as fyn and lck (14) . In general, for mation of IP3 in the activation of tyrosine kinase-linked receptors is slower and the resulting Ca2+ signal is smaller though of longer duration than that due to the activation of G protein-linked receptors (4, 15).
The activation pathway for PLC6, one of the three major PLC families (,3, r and 8), is not known. The enzyme contains one EF-hand motif and may represent a calcium-sensitive form of PLC. The PLCO1 activity is reported to be increased in the aorta of spontaneously hypertensive rats (16). Recently, a high affinity binding of IP3 to the PLC61 isozyme was demonstrated (17). The phospholipase activity of the isozyme was strongly in hibited upon binding of IP3.
III. Structure and expression of IP3 receptor
Subtypes
To date, IP3 receptor has been purified to apparent homogeneity from cerebellum (18, 19), smooth muscle (20-22) and platelet (23). The purified IP3 receptors are glycosylated proteins with molecular masses ranging from 220 to 260 kDa on SDS-PAGE. The Purkinje cells in the cerebellum are a very rich source of the receptor, and hence our current knowledge of the molecular properties of the IP3 receptor originated mostly from studies with the cerebellar receptor. Molecular cloning studies re vealed the existence of at least three types of mammalian IP3-receptor subunits encoded by different genes desig nated as type 1 (24-26), type 2 (27, 28) and type 3 (28 30). Putative type 4 and 5 receptors, which are high ly homologous to the type 2 receptor, have also been sequenced partially (31, 32) .
Among these subtypes, type 1 IP3 receptor, the representative cerebellar receptor, is ubiquitously ex pressed in a wide variety of tissues and is best character ized now. As illustrated in Fig. 1 , the type 1 IP3 receptor is composed of 2,749 amino acids with a calculated Mr of 313 K (an S1'/S2' splicing variant, see below) in the mouse (24) and rat (25). It can be structurally and func tionally divided into three major domains: a ligand-bind ing domain in the NH2-terminal portion (about 24% of the receptor molecule), a coupling or modulatory domain in the middle portion (about 60%) that transduces the signal of ligand binding, and a Ca 21 channel domain in the COOH-terminal portion (33) . The type 2 IP3 receptor is composed of 2,701 amino acids with a calculated Mr of 307 K in the rat (27) and shares 68% sequence identity with the type 1 receptor, while the type 3 IP3 receptor is composed of 2,670 amino acids with a calculated Mr of 304 K in the rat (29) and shares 62% and 64% sequence identity with the type 1 and type 2 receptors, respectively. The overall structural organization is similar for all the three types of receptors. The percent identity among the three subtypes is 68% in the ligand-binding domain, 53% in the coupling domain, and 59% in the Ca 21 channel domain (29). The ligand-binding domain is the most con served region, whereas the coupling domain separating the ligand binding domain from the Ca 21 channel domain is the least conserved. The fact that the conservation is poor in the coupling domain suggests the possible opera tion of different types of regulation at this region among the three types. Alignment of the sequences of the three types of IP3 receptor reveals a scattered and patchy dis tribution of conserved and variable regions (29, 30) as illustrated in Fig. 1 . The ryanodine receptor, another in tracellular Ca2+-release channel, is almost twice as large as the IP3 receptor; nevertheless, it has fragmental se quence homology with the IP3 receptor. Interestingly, the fragmental homology is concentrated in the ligand-bind ing domain and in the Ca 21 channel domain, implying their fundamental roles in the activity of the intracellular Ca2+-release channel (34) .
The type 1 IP3 receptor is further diversified by alter native splicing (35, 36) . Two segments of alternative splicing are known in the receptor: one termed S1 is located in the NH2-terminal ligand-binding domain and codes for 15 amino acids, and the other termed S2 lies in the coupling domain and codes for 40 amino acids (35) as shown in Fig. 1 . In the nervous system, the longer form containing S2 predominates, while the shorter form lack ing S2 predominates in the peripheral tissues (35) (36) (37) . Studies of the mouse receptor have suggested the exist ence of intermediately spliced forms, i.e., the ones with only portions of the splicing segments (35) . However, a detailed study using the RNase protection assay and polymerase chain reaction (PCR) analysis of rat type 1 IP3 receptor did not provide evidence for the existence of intermediately spliced forms (37) , raising the possibility that the degree of alternative splicing of type 1 IP3 recep tor differs in the two very similar species. No alternative splicing was detected at the corresponding positions in either the type 2 or type 3 receptor (38).
Tissue distribution
The type 1 IP3 receptor is the predominant subtype expressed throughout the brain at both the mRNA and protein levels (31, [38] [39] [40] . The level of type 1 receptor in the Purkinje cell in the cerebellum is particularly high, implying its specialized role in the cell type (39) . The type 1 IP3 receptor mRNA is expressed in a neuron-specific manner and present in low to moderate levels in the ol factory tubercle, cerebral cortex, CA1 region of the hip pocampus, caudate-putamen, molecular layer of the cere bellum and choroid plexus (39) . The type 1 IP3 receptor is also widely distributed in tissues other than neuronal tis sues: it is present at relatively high levels in smooth mus cle, including vascular smooth muscle and vas deferens, and platelets and contained at low levels in other tissues (38, 40) . The SI and S2 splicing variants of type 1 IP3 receptor are shown to be expressed in a tissue-specific and developmentally specific manner (35, 41) . S1 splicing variants with or without the S 1 segment show distinct distributions in the brain and peripheral tissues (25, 35, 38, 41, 42) . A S2 splicing variant containing the S2 seg ment is preferentially expressed in the nervous system, while, in contrast, the shorter form lacking S2 is ex pressed predominantly in non-neuronal tissues (35-37, 42). shown. This structural organization is similar for the other two types of IP3 receptors (type 2 and type 3). The position of the two splicing segments, S1 and S2, are shown by an open bar. Transmembrane-spanning segments (M1 to M6) and a putative pore region are indicated. In panel B, putative modulator sites on the type 1 receptor (cerebellar type, S1+/S2+ isoform) are indicated. These include interaction sites for ATP (3 sites), Cat , and calmodulin (CaM) (two sites) in addition to phosphory lation sites for cAMP-dependent protein kinase (PKA) and cGMP-dependent protein kinase (PKG). The two putative N glycosylation sites are also shown. The CaM-binding site numbered 1 indicates the position of the putative CaM site identified in the mouse cerebellar IP3 receptor (114) , while that numbered 2 indicates a putative CaM binding site found in the porcine aortic type 1 IP3 receptor (S2 isoform). The CaM-binding site 2 is shown to be produced by splicing-out of the S2 splicing segment (42) . Although phosphorylation of type 1 IP3 receptor by protein kinase C (PKC) and Ca t+/calmodulin-dependent protein kinase II (CaMKII) was demonstrated, these sites have not been identified. In panel C, amino acid homology among the three types of IP3 receptors is depicted. The scattered and patchy distributions of conserved regions (open box) and variable regions (closed box), each numbered 1 through 13, are shown (30). For more details, see the text.
The type 2 and type 3 IP3 receptors exhibit a more limited distribution, and their expressions are generally at lower levels than the type 1 receptor. PCR and im munoblotting studies indicate that the type 2 receptor is expressed at relatively higher levels in the liver, pancreas, lung, testis and spleen and expressed at much lower levels in the brain including cerebellum (38, 40) . The type 3 receptor is expressed at relatively higher levels in the pancreas, intestine, lung, kidney and brain (29, 38, 40) . The localization of type 3 receptor in astrocytes in the central nervous system of the rat has been immunohisto chemically demonstrated (43) . In general, multiple sub types of IP3 receptor are co-expressed in clonal cell lines irrespective of their origin, although each cell line appears to have its own slightly different pattern of expression (32, 38, 40) .
Subcellular localization
Subcellular localization of type 1 IP3 receptor has been best studied in the cerebellar Purkinje cell (44) (45) (46) . The receptor is abundantly detected in smooth endoplasmic reticulum (ER) with particular enrichment in stacks of flattened cisternae and subplasmalemmal cisternae. A smaller amount of the receptor is also detected in rough ER and outer nuclear membrane, but it does not appear to be present in mitochondria, Golgi complex and plasma membrane. These findings indicate the localization of IP3 receptors to putative intracellular Ca2+ stores, a localization that is compatible with its functional role as an intracellular Ca2+ channel. The plurality of the recep tor in the stacks of flattened ER in the Purkinje cells may explain the exceptionally high concentration of type 1 IP3 receptor in the cell type. On the stacks, the receptors appear to be apposed on an individual stack facing other receptors on the adjacent stack in a head-to-head con figuration forming perpendicular bridges between stacks (47). Although IP3 receptors are widely distributed, only a few studies have been conducted so far regarding the subcellular localizations of IP3 receptors in non neural tissues due probably to their low expression levels (48 50) . Immunoelectron microscopy of rat vas deferens smooth muscle cells revealed the preferential clustering of IP3 receptor in peripheral smooth ER, where calseques trin, a luminal Ca2+ binding protein, was also enriched (49) . In mouse choroidal cells, IP3 receptor immuno reactivity was localized on the surfaces of several endo membrane systems including clear vesicles, tubules and vesicular profiles of smooth ER, rough ER and a part of the nuclear envelope, as well as clusters of ribosomes in the cytoplasmic matrix (50) . The heart is known to be the tissue where IP3 receptors are rarely expressed. However, the type 1 IP3 receptor has been recently immunolocalized in rat hearts to intercalated discs of ventricular myocytes, while in contrast, the ryanodine receptor was observed in coincidence with the triad junction at the I-bands (51) . The localization of the IP3 receptor to intercalated discs of ventricular and atrial myocytes was also confirmed by immunoelectron microscopy. These results suggest a pos sible role of IP3 receptor in Ca 2+ entry through inter calated discs or intercellular signaling between cardio myocytes.
Evidence for close association of IP3 receptor with the plasma membrane was provided from cell fractionation studies that demonstrated the co-purification of IP3 receptors with plasma membrane markers (52) (53) (54) (55) . These IP3 receptors appeared to be located in a subcompartment of ER that was tightly bound to the plasma membrane since the receptors could be dissociated by treatments that disrupt the cytoskeleton (53, 55) . Thus, the receptor seems to interact indirectly with the plasma membrane via the cytoskeleton. Binding sites for ankyrin, an adaptor protein connecting integral plasma membrane proteins to the cytoskeleton, have been demonstrated in IP3 receptors (56) (57) (58) . The close association of IP3 receptor with the plasma membrane conforms with the conformational coupling model for "capacitative calcium entry", a theory according to which the entry of external Ca2+ is regulated by the state of filling of intracellular Ca 2+ stores (59) . In this model, IP3 receptors sense the filling state of luminal Ca2+ and transmit the information through their large cytoplasmic heads directly to Ca 2+ entry channels on the plasma membrane.
The localization of an IP3 receptor-like protein in the plasma membrane of various cell types including endo thelial cells, smooth muscle cells and keratinocytes was demonstrated by immunocytochemical and immuno chemical techniques (48) . Interestingly, the protein was confined to caveolae, smooth invaginations of the plasma membrane where the plasma membrane Ca2+-extrusion pump was also co-localized (60) , implying that the caveolae is a site of specialization for Ca2+ entry and extrusion. The presence of an IP3 receptor-like protein in the plasma membrane was also demonstrated in some tissues or cells such as T lymphocytes and olfactory cilia (61, 62) . In these cells, the presence of an IP3-gated Ca 2+ channel in the plasma membrane was demonstrated (63) . Increase in the expression of type 3 IP3 receptor has been recently demonstrated during the apoptosis of lympho cytes (64) . The induced receptor was localized to the plasma membrane. Antisense cDNA to type 3 IP3 recep tor blocked the apoptosis, whereas either the sense probe to type 3 IP3 receptor or antisense probe to type 1 IP3 receptor did not. These results suggest that the selective expression of type 3 IP3 receptor and their localization to the plasma membrane cause enhanced Ca2+ entry, lead ing to apoptosis. Furthermore, overexpression of type 3 IP3 receptor in Xenopus oocytes had no effect on IP3-in duced Ca2+ release but it markedly enhanced capacitative Ca2+ entry. The type 3 IP3 receptor was found to be localized preferentially to subplasmalemmal cisternae (65) . These findings suggest a functional association of 4. Molecular structure The molecular architecture of IP3 receptor is well characterized for the type 1 receptor. As illustrated in Fig.  1 , the type 1 IP3 receptor is structurally and functionally divided into three parts: the NH2-terminal ligand binding domain, the coupling or modulatory domain and the COOH-terminal Ca 21 channel domain (33) . The ligand binding domain together with the coupling domain con stitute a large cytoplasmic head amounting to about 83% of the molecule. Electron microscopic observations (19, 20), a cross-linking study (66) , and sucrose density gradient experiments (44) have suggested that the IP3 receptor subunit tetramizes to form an IP3-gated Ca2+ channel. The expression of multiple subtypes of IP3 receptor subunit in individual cells raises the possibility that a heterotetrameric IP3 receptor is formed besides a homotetrameric IP3 receptor. Indeed, the existence of heterotetrameric IP3 receptors has been demonstrated in cultured cells (67) (68) (69) and rat liver (67) . Different IP3 receptor subtypes with distinct regulatory and Ca2+ channel properties will endow these heterotetrameric receptors with further functional diversity.
IP3 binding domain: IP3 binds to a single binding site in the NH2-terminal ligand binding domain of the type 1 IP3 receptor subunit (18-23). Therefore, the tetrameric receptor complex can bind four IP3 molecules. Scatchard analyses of the kinetics of IP3 binding to the receptor in dicate no co-operativity giving Hill coefficients of around 1. The binding is of high affinity with KD values ranging 2 to 100 nM and is highly specific to IP3 (D-myo-inositol 1,4,5-trisphosphate) among various inositol phosphates. The inositol phosphate specificity and affinity are essen tially the same in membranes and purified receptors (18, 21). About 650 amino acids of the NH2-terminus was originally assigned to the portion required for IP3 binding by deletion experiments (70) . A recent more detailed study (71) has revealed the presence of a "core" region for IP3 binding in the N-terminal residues from 226 to 578 of the type 1 receptor, where three basic amino acids (Arg 265, Lys-508 and Arg-511) are conserved among all sub types of IP3 receptor, and are shown to be essential for the IP3 binding by mutagenesis experiments. These find ings predict a critical pH dependency of the IP3 binding to the receptor. Indeed, the binding is known to be increased at alkaline pH with the optimum around 9 and reduced at acidic pH: the binding at pH 8.5 9 is two to three-fold greater than that at pH 7.5 (18, 20, 21). The steep slope of the pH curve for IP3 binding provides a basis for sensitive regulation of IP3 action that can be seen in response to alterations of intracellular pH.
Heparin is a potent competitive antagonist of the IP3 receptor. It inhibits IP3 binding to purified receptors (18-23) as well as the release of Ca2+ from intracellular stores (72, 73) , and IP3-gated Ca 2+ channel activity (74) . However, its usefulness as a pharmacological tool for studies on intact cells is hampered because it may also inhibit the formation of IP3 and activate the ryanodine receptor (75) . Adenophostin A and B are newly discover ed, potent and metabolically resistant agonists of IP3 receptors (76, 77) . In spite of structural differences from IP3, adenophostins activate Ca 2+ release channels with a potency 10 to 100-fold greater than IP3i and their actions are completely blocked by heparin.
Coupling domain: The coupling domain separating the ligand binding domain from the Ca 21 channel domain is supposed to serve as a target of regulatory signals for the IP3-gated Ca 2' release channel as well as a functional domain to transduct the IP3 binding signal to the Ca 2+ channel (33) . As shown in Fig. 1 , the domain contains putative binding sites for various modulators of the channel such as ATP, Ca 2+, calmodulin (CaM), FK506 binding protein 12 (FKBP 12), and phosphorylation sites for several protein kinases including cAMP-dependent protein kinase (PKA), cGMP-dependent protein kinase (PKG), PKC and Ca 2+/calmodulin-dependent protein kinase II (CaMKII). These structural features found in this domain predict a complex regulation of IP3-induced opening of Ca2+ channels. Many intracellular signaling pathways converge on this domain. We will later focus on several related mechanisms involved in the regulation of IP3 receptor. As noted above, the homology among different IP3 receptor subtypes is the lowest in the coupling domain, suggesting the operation of differential regulation in different subtypes.
Ca 2+ channel domain: The hydropathy profile of the amino acid sequence of the Ca2+ channel domain predicted the presence of six (78) or eight (33) transmem brane-spanning segments that are presumed to be assem bled in the ER membrane to constitute the Ca2+ channel. A recent detailed study (79) on the transmembrane topol ogy of the mouse type 1 IP3 receptor confirmed the six transmembrane-spanning segments model: the six trans membrane segments (M1 to M6) and a putative pore forming region between M5 and M6 segments constitute the Ca 2+ channel. Furthermore, two N-glycosylation sites were located in the luminal loop between the M5 segment and the pore-forming region. The two corre sponding glycosylation sites exist in rat (25) and human (26) type 1 IP3 receptors and two consensus sites for N glycosylation are found in rat (27) and human (28) type 2 IP3 receptors at the positions equivalent to those in type 1 IP3 receptor. Only one corresponding site is found in rat (29) and human (28) type 3 IP3 receptors. The transmem brane-spanning segments are also supposed to be required for the oligomerization of four IP3 receptor subunits (70) . The function of the cytoplasmic COOH-terminal tail is unclear. Its involvement in the Ca 21 channel activity is, however, suggested since a monoclonal antibody recog nizing a portion of the COOH-terminus was reported to block generation of Ca2+ wave and oscillation in ferti lized hamster eggs (80) . Thus, the IP3 receptor-Ca 2+ channel complex is composed of four subunits, each con taining six transmembrane-spanning segments, and be longs to the superfamily of voltage-gated (81) and second messenger-gated channels (82) .
IV. Function of IP3 receptor 1. Ca 2+ channel
As evidenced by the ligand binding data, the purified IP3 receptor clearly satisfies the properties of a physiolog ical receptor for IP3. That both IP3 receptor and Ca2+ re lease channel reside in the same protein was first suggest ed by single channel analyses using planer lipid bilayers reconstituted with microsomal proteins from aortic smooth muscle (74) . The experiments with purified type 1 IP3 receptor incorporated into reconstituted vesicles (83) or planer lipid bilayers (66, 84) further provided evidence that both IP3 receptor and Ca2+ channel are integrated in the same molecule. Thus, the IP3 receptor is analogous to other ligand-gated ion channels except for its primary as sociation with intracellular membranes.
Our current knowledge about the Ca 21 channel properties of IP3 receptor has been provided mainly from single channel analyses using planer lipid bilayers recon stituted with crude microsomal proteins from cerebellum (for a review, see ref. 8 ). The channel properties of type 2 and type 3 IP3 receptors are largely unknown. The Ca2+ channel of the cerebellar IP3 receptor (type 1) is activated by IP3i the only known physiological activator, with an EC50 of around 0.2 pM: it can maximally activate the channel at 1 uM. The IP3 receptor, when activated, can conduct all four alkaline earth cations with conductances in the order of Ba2+ > Sr2+ > Ca 2+ > Mg2+. The ryanodine receptor can also conduct these divalent cat ions in this order, although conductances are approxi mately twice as large for the ryanodine receptor. Both channels also have a similar selectivity for divalent cat ions over monovalent cations, but their selectivities are much lower than the extreme selectivity found with plas ma membrane L-type Ca 21 channels, implying different mechanisms of ion permeation between the two intracel lular and the plasma membrane Ca2+ channels. Thus, the Ca 2+ channel of the IP3 receptor as well as the ryanodine receptor is a rather nonspecific cation selective channel permeable to Ca2+ and monovalent cations, quite a con trast to the actually absolute Ca2+-selective nature of the L-type Ca 2+ channel. The observed similarity of Ca 2+ channel properties of the IP3 receptor and the ryanodine receptor is not sur prising because these two channels exhibit a remarkable homology in the transmembrane-spanning regions as not ed above (44) . However, under a physiological condition in the presence of symmetrical 110 mM K+ and luminal free Ca2+ concentration of 2.5 mM, unitary Ca2+ current through the IP3 receptor was estimated to be about 0.5 pA (85), an estimate fourfold lower than that through the ryanodine receptor under the identical conditions. Fur thermore, the mean open time of the IP3 receptor under physiological conditions is 3.7 msec (85), while that of the ryanodine receptor is about 20 msec, 5 times longer than that of the IP3 receptor. Thus, the two intracellular Ca 2+ channels differ in the amount of Ca 2+ released upon opening: the ryanodine receptor discharges about 20 times more Ca2+ per each opening than the IP3 receptor through which 5,400 Ca 2+ ions are estimated to be re leased at every channel opening (85).
Modulation by cytoplasmic Ca 21
Cytoplasmic Ca2+ was once shown to inhibit IP3 induced Ca2+ release in cerebellar microsomes with an IC50 of 300 nM by decreasing IP3 binding to microsomes (18). However, experiments with permeablized smooth muscle revealed a biphasic effect of cytoplasmic Ca2+ on the IP3-induced Ca2+ release with a maximum rate of re lease occurring at 300 nM Ca 2+ (86) . Experiments with caged Ca 2+ that permitted analysis with a much improved time resolution indicated that both activating and inhibi tory effects of Ca2+ on the IP3-induced Ca2+ release in permeabilized smooth muscle were extremely rapid, which would allow for immediate feedback control of IP3-induced Ca 2+ release (87) .
The regulatory effects of Ca2+, either activation or in hibition, seems to be produced by direct action of Ca2+ on the receptor since it is very fast and reversible, and it also occurs in a reconstituted system using planar lipid bilayers (88) . The observations that the purified IP3 receptor binds Ca2+ (89) , and at least one Ca2+ binding site resides in the coupling domain of the receptor (90), may lend support to the idea of a direct effect of Ca2+. Although the existence of a Ca2+-binding protein, desig nated as calmedin, was proposed to explain the inhibi tory action of Ca 2+ on IP3 binding to the cerebellar microsomes (91) , its identification and physiological sig nificance remain to be elucidated. Recent experiments with the purified IP3 receptor from Xenopus oocytes sug gested that some associated protein or factor mediates the inhibitory action of Ca 2+ but the activating site is located on the IP3 receptor molecule (91) .
The bell-shaped dependence on cytoplasmic Ca2+ is also shared by the ryanodine receptor (88) . However, the inhibitory action of Ca2+ on the receptor is exerted only in the millimolar range, much higher than the physiologi cal concentrations. The Ca 2+-release from the ryanodine receptor, therefore, displays only Cat+-dependent activa tion in the physiological range of cytoplasmic Ca2+ con centrations, while in contrast, the IP3 receptor exhibits both Ca2+-dependent activation and inhibition in the physiological concentrations of Ca2+. The Ca 2+-depend ent activation of IP3 receptors also suggests that the IP3 receptor can act as a Ca2+-induced Ca2+ release channel in the presence of a fixed concentration of IP3 if the cytoplasmic Ca2+ concentration is less than 300 nM. The property of IP3 receptor as a Ca2+-induced Ca2+ release channel is well-documented in experiments with single smooth muscle cells: a slow rise in intracellular Ca2+ in agonist-stimulated cells was followed by a wave of rapid regenerative Ca2+ release as the local Ca 21 concen tration reached a critical concentration of approximately 160 nM (92) . Recent developments of Ca 2+-imaging tech niques revealed that many of the cells responding to IP3 generating external stimuli display a repetitive pattern of Ca 2+ spikes (calcium oscillation) or Ca 2+ oscillation propagation without decay of amplitude through the cytoplasm of the cell (calcium wave). The bell-shaped Ca2+-dependence of IP3 receptor channel opening is now generally recognized as an essential mechanism that is re quired for generation of the calcium wave and oscillation (for reviews, see refs. 2-4).
Modulation by adenine nucleotide
ATP was initially found as a cofactor necessary for IP3-induced Ca 2+ release (93) . The action of ATP on IP3 receptor was studied in detail by experiments using IP3 receptor purified from the cerebellum and incorpo rated into liposomes (94) . Supporting the earlier observa tions, 10 pM ATP or nonhydrolyzable ATP analogs mark edly potentiated IP3-induced Ca2+ flux into the recon stituted lipid vesicles. AMP and GTP were without effect in the activation of the IP3 receptor. The submillimolar concentrations of ATP and its nonhydrolyzable analogs also potentiated the IP3-induced Ca2+ release in perme abilized vascular smooth muscle cells (95) . Single channel data analysis indicated that ATP activated the IP3 recep tor by increasing both open probability and open time (96) .
A specific binding site for ATP was detected in purified type 1 IP3 receptor subunit (65) , and two consensus sequences for ATP binding site were found in its amino acid sequence (24, 25), both located in the coupling domain of the receptor. The other two subtypes of IP3 receptor, type 2 (27, 28) and type 3 (28 30), also contain a consensus sequence for ATP binding site in positions corresponding to that in type 1 IP3 receptor, implying that these two subtypes are also under regulation by ATP.
Since the binding of ATP to IP3 receptor did not affect IP3 binding, it is reasonable to speculate that ATP bind ing to the coupling domain of IP3 receptor affects in an allosteric manner the coupling efficacy of IP3 binding and Ca2+ channel opening.
Interestingly, the activity of the ryanodine receptor is also known to be allosterically potentiated by submilli molar levels of ATP (97): ATP potentiates the channel by increasing both open time and open probability. This form of regulation by ATP suggests a close coupling be tween intracellular Ca2+ release and cellular energy level, and it may play a role in the preservation of cells under energy starvation such as those in ischemic heart and brain by reducing intracellular Ca2+ release, leading to reduced consumption of ATP and prevention of Ca2+ overload.
Modulation by phosphorylation
Earlier reports have already shown that cerebellar P400
protein (98) or PCPP-260 protein (99) , both now known to be identical with type 1 IP3 receptor, is one of the good substrates for PKA. Detailed biochemical analyses per formed after purified type 1 IP3 receptor became available revealed that it was also a substrate for PKC and CaMKII in addition to being a substrate for PKA (100) . Phospho rylation of the receptor by these kinases was stoichio metric (one phosphate/one receptor subunit) and addi tive, indicating the presence of distinct phosphorylation sites for different kinases (100). Two putative phospho rylation sites for PKA were also found in the amino acid sequence of the type 1 IP3 receptor, both being located in the coupling domain (24, 25) (Fig. 1) . One of the two sites (Ser-1755, numbering based on that of rat type 1 IP3 receptor (25)) was found to be preferentially phospho rylated by PKA, while another site (Ser-1589) became phosphorylated when the concentration of PKA was in creased (100, 101) . Splicing of the S2 segment (coding for 40 amino acids) located between the two phosphorylation sites for PKA seems to affect phosphorylation by PKA: type 1 IP3 receptor purified from cerebellum, i.e., S2+ isoform, was phosphorylated primarily on Ser-1755, whereas the receptor purified from vas deferens, i.e., S2 isoform, was phosphorylated almost exclusively on Ser-1589 (36) . The different tissue distribution of S2 splicing variants and their differential phosphorylation by PKA may contribute to tissue-specific regulation of IP3 receptor activity by cAMP signaling pathways.
The phosphorylation of type 1 IP3 receptor by PKG was originally demonstrated in vascular smooth muscle (102) . A 240-kDa protein, found as a PKG substrate whose phosphorylation was in a close association with the stimulation of plasma membrane Ca 2+ pump by the kinase (102), was later shown to be identical with type 1 IP3 receptor (22, 42) . The phosphorylation of the type 1 IP3 receptor by PKG was independently demonstrated by Komalavilas and Lincoln (103) . The receptor purified from cerebellum (S2+ isoform) was phosphorylated by PKG almost exclusively on Ser-1755, corresponding to one of the two phosphorylation sites for PKA. Phospho rylation of the IP3 receptor in intact vascular smooth muscle in response to cGMP-generating vasodilators or metabolically resistant cGMP analogs has been recently demonstrated (104) . The IP3 receptor was similarly phos phorylated by stimulation with forskolin, an agent that directly activates adenylate cyclase and increases cAMP level. However, the sensitivities of these phosphorylations to various protein kinase inhibitors suggest that PKG mediates phosphorylation of IP3 receptor in response to increases of both cAMP and cGMP in intact cells (104) . Thus, in some cell types such as the vascular smooth muscle cell, it is conceivable that both cAMP and cGMP signaling pathways regulate IP3 receptor activity through activation of PKG and the resultant phosphorylation of the receptor.
The functional consequences of phosphorylation of IP3 receptor are equivocal. The phosphorylation of IP3 receptor in microsomes from cerebellum resulted in a decreased sensitivity of IP3-induced Ca2+ release to IP3 without any effect of IP3 binding to the receptor (105) . Similar inhibition provoked by PKA phosphorylation of IP3 receptor was also demonstrated in platelet membranes (106) . Both cAMP and cGMP or agents that increase one or both cyclic nucleotides were shown to inhibit IP3 induced Ca 2+ release in intact or permeabilized gastric smooth muscle (107) . In contrast to these observations, activation of either PKA or PKG has been shown to cause potentiation of IP3-induced Ca2+ release in permeabilized hepatocytes (108) (109) (110) .
A recent study with affinity (42) demonstrated that the CaM-binding is a property intrinsic to the type 1 IP3 receptor expressed in non-neuronal tissues which lacks the S2 splicing segment. A sequence that characterizes the CaM binding domains of representative CaM-binding proteins such as plasma membrane Ca2+-pump ATPase and myosin light chain kinase is found in the type 1 IP3 receptor of porcine aorta, and it is postulated to represent the calmodulin binding site of the receptor. In the cerebellar IP3 receptor that contains the S2 splicing segment, the sequence is separated at the mid-point through insertion of the S2 splicing segment. This may be the reason why the CaM binding property is lacking in the cerebellar type 1 IP3 receptor. The physiological significance of CaM binding to the IP3 receptor remains to be clarified.
The ryanodine receptor also contains calmodulin bind ing domains (115) . The postulate that Ca 2+ release through the receptor is negatively regulated by CaM (116) has been recently demonstrated in the photoresponse process in Drosophila photoreceptors (117) .
It has been recently reported that the immunophilin protein FKBP 12 is physically associated with the IP3 receptor and the ryanodine receptor (118) . 
